Stockscreener 앱 받기
4.82
0.62%
-0.03
시간 외 거래:
4.86
0.04
+0.83%
Nuvation Bio Inc 주식(NUVB)의 최신 뉴스
Nuvation Bio Inc. (NUVB) turns bullish amid positive regulatory trajectory in Europe - MSN
Nuvation Bio gains global rights to brain cancer therapy from Daiichi Sankyo - MSN
Ibtrozi Prospects Asserts Nuvation Bio Inc. (NUVB) as one of the Best Healthcare Penny Stocks - Insider Monkey
Nuvation Bio Executive Share Sale: CRO Kerry Wentworth Sells 200,000 SharesNews and Statistics - IndexBox
Market Fear: Is Nuvation Bio Inc stock undervalued right nowGap Down & Weekly Sector Rotation Insights - baoquankhu1.vn
Risk Hedge: Is Nuvation Bio Inc stock undervalued right nowWeekly Market Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB) - Yahoo Finance
Insider Sells 200K Shares of Biotech Company Nuvation Bio (NUVB) - The Motley Fool
Wedbush Bullish on Nuvation Bio (NUVB) As NUVB Expands Safusidenib Rights - Insider Monkey
Nuvation Bio (NUVB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Aug Big Picture: Is Nuvation Bio Inc stock a hidden gemWeekly Stock Analysis & Daily Profit Maximizing Tips - baoquankhu1.vn
Nuvation Bio Inc. (NUVB): Billionaire David Abrams has a long-term bet on this stock - MSN
NUVB Stock Price, Quote & Chart | NUVATION BIO INC (NYSE:NUVB) - ChartMill
Analysts Are Bullish on These Healthcare Stocks: GE Healthcare Technologies Inc (GEHC), Nuvation Bio (NUVB) - The Globe and Mail
RBC Capital Sticks to Their Buy Rating for Nuvation Bio (NUVB) - The Globe and Mail
Nuvation Bio officer Wentworth sells $903k in shares By Investing.com - Investing.com Canada
Nuvation Bio officer Wentworth sells $903k in shares - Investing.com
Nuvation Bio stock rating reaffirmed at Buy by Truist Securities - Investing.com Australia
Truist Financial Maintains Nuvation Bio(NUVB.US) With Buy Rating, Announces Target Price $4.51 - Moomoo
RBC Capital Maintains Nuvation Bio(NUVB.US) With Buy Rating, Raises Target Price to $20 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Nuvation Bio Inc. (NUVB) And Encourages Shareholders to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Nuvation Bio Inc. (NUVB) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Nuvation Bio Inc. (NUVB) and Eisai get EMA validation for taletrectinib - MSN
JonesTrading Maintains Nuvation Bio(NUVB.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Nuvation Bio Inc. (NUVB) Turns Bullish amid Positive Regulatory Trajectory in Europe - Yahoo Finance
[144] Nuvation Bio Inc. SEC Filing - Stock Titan
RBC Capital raises Nuvation Bio stock price target on glioma potential - Investing.com Canada
RBC Capital raises Nuvation Bio stock price target on glioma potential By Investing.com - in.investing.com
RBC Raises Price Target on Nuvation Bio to $20 From $13, Keeps Outperform, Speculative Risk - marketscreener.com
JPMorgan Chase & Co. Purchases 557,656 Shares of Nuvation Bio Inc. $NUVB - MarketBeat
Capricorn Fund Managers Ltd Makes New Investment in Nuvation Bio Inc. $NUVB - MarketBeat
Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-04-05 | Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:NUVB | Press Release - Stockhouse
10 Best Multibagger Penny Stocks to Invest In - insidermonkey.com
Aug Reactions: Is Nuvation Bio Inc exposed to currency risks2026 Price Momentum & Daily Profit Focused Stock Screening - baoquankhu1.vn
Is EMA Validation Of Taletrectinib Expanding Nuvation Bio’s (NUVB) Targeted Lung Cancer Opportunity? - Sahm
Bronstein, Gewirtz & Grossman, LLC Encourages Nuvation Bio Inc. (NUVB) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bullish analyst sentiment on Nuvation Bio (NUVB) amid early commercialization progress - MSN
2026-04-03 | Bronstein, Gewirtz & Grossman, LLC Encourages Nuvation Bio Inc. (NUVB) Shareholders to Inquire about Securities Investigation | NYSE:NUVB | Press Release - Stockhouse
Nuvation Bio Inc. (NUVB) amends protocol on safusidenib trials in astrocytoma - MSN
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact L - GuruFocus
Nuvation Bio Inc. (NUVB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Kuehn Law Encourages Investors of Nuvation Bio Inc. to Contact Law Firm - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Nuvation Bio Inc. (NUVB) And Encourages Investors to Connect - ACCESS Newswire
2.69%
0.25%
자본화:
|
볼륨(24시간):